-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BO8E8LpFaVqZ99ovvMeI9EZBdT206yXkwrJsNCm9DyB7jNrSroIpbjb+4QBx4V7i S3ddqFQbW4qoDU4QwFhesQ== 0001303527-04-000001.txt : 20040924 0001303527-04-000001.hdr.sgml : 20040924 20040924154931 ACCESSION NUMBER: 0001303527-04-000001 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040914 FILED AS OF DATE: 20040924 DATE AS OF CHANGE: 20040924 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI MOLECULAR IMAGING INC CENTRAL INDEX KEY: 0001129552 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 621377363 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 810 INNOVATION DRIVE CITY: KNOXVILLE STATE: TN ZIP: 37932 BUSINESS PHONE: 8652182000 FORMER COMPANY: FORMER CONFORMED NAME: CTI INC /TN DATE OF NAME CHANGE: 20001206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andreaco Mark S CENTRAL INDEX KEY: 0001303527 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49867 FILM NUMBER: 041045073 BUSINESS ADDRESS: BUSINESS PHONE: 865.218.2000 MAIL ADDRESS: STREET 1: 810 INNOVATION DRIVE CITY: KNOXVILLE STATE: TN ZIP: 37932 3 1 primary_doc.xml PRIMARY DOCUMENT X0202 3 2004-09-14 0 0001129552 CTI MOLECULAR IMAGING INC CTMI 0001303527 Andreaco Mark S 810 INNOVATION DRIVE KNOXVILLE TN 37932 0 1 0 0 Senior V.P. - PETNET Solutions Stock Option (right to buy) 2.8125 1997-12-12 2004-12-12 Common Stock, par value $0.01 14080 D Stock Option (right to buy) 2.8125 1999-05-17 2006-05-17 Common Stock, par value $0.01 7040 D Stock Option (right to buy) 4.6875 2001-09-30 2008-09-30 Common Stock, par value $0.01 6400 D Stock Option (right to buy) 5.5625 2002-04-12 2009-04-12 Common Stock, par value $0.01 10787 D Mark S. Andreaco 2004-09-24 EX-24 2 exh24-1andreacopoa.txt SPECIAL POWER OF ATTORNEY - MARK S. ANDREACO SECTION 16 SPECIAL POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints David N. Gill and Jack H. McCall, Jr., or any of them, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or 10% shareholder of CTI Molecular Imaging, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 and timely file such form with the Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 17th day of September, 2004. /s/ Mark S. Andreaco --------------------- Mark S. Andreaco CONFIRMING STATEMENT This Statement confirms that the undersigned, Mark S. Andreaco, has authorized and designated David N. Gill and Jack H. McCall, Jr. or any of them to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of CTI Molecular Imaging, Inc. The authority of David N. Gill and Jack H. McCall, Jr. under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of CTI Molecular Imaging, Inc., unless earlier revoked in writing. The undersigned acknowledges that David N. Gill and Jack H. McCall, Jr. are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended. Date: September 17, 2004 /s/ Mark S. Andreaco --------------------- Mark S. Andreaco -----END PRIVACY-ENHANCED MESSAGE-----